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INSIGHTS
ILC2s chew the fat
Roberto R. Ricardo-Gonzalez1 and Richard M. Locksley2,3,4
In this issue of JEM, Rana et al. (https://doi.org/10.1084/jem.20190689) report that adipose tissue multipotent stromal cells (MSCs) provide
multifaceted support for adipose tissue–resident ILC2s through contact-mediated proliferation and IL-33–mediated stress-induced activation.
Allergy is a disease canonically associated
with adaptive IgE-mediated aversive re-
sponses. The discovery of group 2 innate
lymphoid cells, ILC2s, has provoked a new
look at this arm of immunity and evokes the
concept of "innate allergy," which remains
confusing. In the mouse, ILC2s first appear in
tissues in late fetal development and, upon
birth, undergo massive proliferation and ex-
pansion while acquiring transcriptional pro-
grams attuned to the tissues in which they
dwell (Schneider et al., 2019). As such, ILC2s
resemble a spectrum of pre- and perinatally
positioned tissue-resident immune cells—
from fetal macrophages to γδ T cells to thy-
mic T regulatory (T reg) cells—that hints at
complex roles for the immune system in tis-
sue homeostasis (Gasteiger and Rudensky,
2014). Indeed, ILC2s express a variety of cy-
tokine, neuropeptide, and lipid receptors that
have roles in integrating signals from diverse
cell types in orchestrating innate allergy by
their discharge of IL-5, IL-13, and other
mediators.
Although developing after birth, white
adipose tissue was noted to be infiltrated
with ILC2s since their initial published de-
scription (Moro et al., 2010). Subsequent
studies revealed ILC2s to be critical for sus-
taining healthy adipose tissue, in part by
establishing immune tone necessary to cur-
tail development of an inflammatory state
and insulin intolerance (Molofsky et al.,
2013). But why are ILC2s there? What
keeps them there, and what do they do?
Adipose ILC2s constitutively express high
levels of the IL-33 receptor, ST2, and re-
spond rapidly to exogenous IL-33 (Molofsky
et al., 2015). In the current issue of JEM, Rana
et al. used IL-33 reporter mice to identify the
major reservoir of IL-33 to be adipose
PDGFRα+ multipotent stromal cells (MSCs),
which the authors confirm by their capacity
to differentiate into adipocytes or α-smooth
muscle actin+ myofibroblasts in vitro. Iso-
lated adipose MSCs induced activation and
proliferation of purified ILC2s in culture, but
surprisingly, proliferation was maintained
even by IL-33–deficient MSCs, though only
when cell–cell contact was sustained by in-
teractions between ICAM-1 on MSCs and
LFA-1 on adipose ILC2s. In turn, cytokines
from ILC2s induced eotaxin (CCL11), leading
to tissue eosinophil influx. Thus, specialized
adipose MSCs sustain constitutive ILC2s,
since their numbers and activation profile
were diminished in LFA-1–deficient mice,
through both contact-mediated constitutive
mechanisms and IL-33–mediated induced
mechanisms, and ILC2 type 2 cytokines,
likely IL-13, were required to maintain con-
stitutive nuclear IL-33 levels in MSCs.
Interest in these adipose interactions has
provoked contemporaneous investigations
using independent approaches to track the
relationship of ILC2s with tissue reservoirs
of IL-33. Mahlakõiv et al. (2019) used IL-33
reporter mice to identify a similar popula-
tion of adipose stromal cells, designated
adipose stem and progenitor cells, as well as
a lesser population of podoplanin+PDGFRα–
stromal cells in the fat pad–enveloping
mesothelium. High-fat diet induced rapid
IL-33 loss from adipose stem and progenitor
cells and protection from the increases in
weight and adipocyte numbers seen in the
absence of IL-33 or ST2. The authors sug-
gested that IL-33 from mesothelial lining
cells might function more as an alarmin
released after tissue perturbation through
expansion or injury. Spallanzani et al. (2019),
with a long interest in adipose ST2+ T reg
cells, also localized IL-33 predominantly to
adipose PDGFRα+Sca1+ stromal and mesothe-
lial cells, but single-cell RNA sequencing
(RNA-seq) and bulk RNA-seq analysis parsed
the former to define a more proliferative
subtype with a prominent epithelial–
mesenchymal transition profile. They
suggested that “immunocyte-promoting”
stromal cells constitute a unique adipose
population, as compared with “adipocyte-
generating” stromal cells by a process
largely dependent on IL-33. Strikingly, ad-
ipose T reg cells and IL-33 were much more
prominent in male as compared with fe-
male mice. Finally, Dahlgren et al. (2019)
took an orthogonal approach by micro-
scopically localizing ILC2s in several tissues
to demonstrate their prevalence in adven-
titial cuffs, “virtual” collagen-rich matrices
that surround intermediate blood vessels
and provide conduits for collecting inter-
stitial fluids for routing to lymphatics that
egress from these specialized sites. ILC2s
were also prominent in mesothelial serosa,
including the pleura and adipose capsule as
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seen in the other studies. The adventitial
stromal cells, or ASCs, supporting the ILC2
niches were PDGFRα+Sca1+podoplanin+ cells,
the majority (∼60%) of which expressed IL-
33. Single-cell RNA-seq revealed expression
of eotaxin (CCL11), but also thymic stromal
lymphopoietin (TSLP), consistent with a tis-
sue ILC2 niche, which was supported further
by expression of IL-7 in lymphatic endothelia
abutting the adventitial cuffs. Similar pop-
ulations of ASCs were present in gonadal
adipose tissue, as were the mesothelial IL-33+
capsular stromal cells, in agreement with the
other studies. Activation of ILC2s drove ex-
pansion of IL-33+ lung ASCs which was
mimicked by IL-13, and deletion of IL-33 from
ASCs limited Th2 accumulation in the lung
after migratory helminth infection.
Although there remain some discrep-
ancies, each of these studies points to
unique stromal cell populations as a major
source of IL-33 at sites populated by ST2+
ILC2s (and likely T reg cells) and generates
momentum for addressing the signals that
lead to export of IL-33 protein from ASCs to
target immune cells. ILC2s position nor-
mally in IL-33- and ST2-deficient mice,
suggesting a role in activation and/or turn-
over rather than spatial organization by IL-33,
but the ASCs have additional mechanisms
(e.g., ICAM-1, TSLP) to impact ILC2s and other
immune cells, as revealed by these studies.
Are these specialized stromal cells related to
the PDGFRα+podoplanin+ mesenchymal cells
that mediate tissue differentiation of fetal
ILC2 precursors in conjunction with Notch
and IL-7 (Koga et al., 2018)? Do these stromal
cells constitute the tissue “checkpoints” that
release type 2 cytokines from infiltrating ac-
tivated lymphocytes (Van Dyken et al.,
2016)? The large datasets generated by these
investigations will allow construction of more
precise reagents to define subsets of these
stromal populations that govern critical sites
where immune cells leverage decisions be-
tween tissue support of homeostasis versus
emergency interdiction of pathogenic invaders.
ILC2s (and T reg cells) are prevalent in
cutaneous and mucosal tissues and are im-
portant for homeostasis in response to en-
vironmental perturbations mediated by
microbiota, metabolites, food, and patho-
genic insults. It is reasonable to ask
whether the positioning of ILC2s and T reg
cells in white adipose depots may be im-
portant in the integration of systemic
metabolic demands as dictated by the pe-
ripheral tissues. Examples of such crosstalk
have been noted. During Trichuris muris
infection, inhibition of fatty acid metabo-
lism led to a reduction in the number of
ILC2s, their production of type 2 cytokines,
and attenuation of worm expulsion that
was not seen following inhibition of glucose
utilization and was consistent with skew-
ing of energy needs to fatty acids to gen-
erate the sustained mucosal response
required to deal with this organism
(Wilhelm et al., 2016). Conversely, infection
with the migratory helminth Nippos-
trongylus brasiliensis improved insulin re-
sistance otherwise associated with high-fat
diet (Wu et al., 2011), consistent with sys-
temically integrated metabolic alterations
to meet specific tissue demands, but how
these systemic responses become inte-
grated in visceral adipose stores is unclear.
Of note, N. brasiliensis infection was ac-
companied by mobilization of ILC2s into
the circulation (Huang et al., 2018), thus
creating a mechanism by which type 2 cy-
tokines could be systemically disseminated,
akin to hormones. In this way, the mobili-
zation of resident ILC2s from tissue in
response to local perturbations could dis-
tribute type 2 cytokines to adipose stores to
induce levels of IL-33 on specialized stro-
mal mesenchymal cells, as shown in the
articles discussed above, and thus reset the
metabolic tone of the tissue. Further study
is needed to explore the interplay between
ILC2 activation and IL-33–expressing stro-
mal cells in adipose tissues, and what the
metabolic consequences might be in pars-
ing the line between host defense and tol-
erance in respect of tissue function
(Ganeshan et al., 2019). The work by Rana
et al. (2019), as well as those additionally
highlighted, have begun to point the way
forward in this fascinating area of biology ad-
dressing the evolutionary underpinnings of
allergic immunity.
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